趙 庭興

Medicine & Life Sciences

1. Thrombomodulin 60%
2. Cilostazol 59%
3. Myocardial Infarction 47%
4. Cardiology 45%
5. Coronary Artery Disease 36%
6. Cardiovascular Diseases 33%
7. Guidelines 28%
8. Proprotein Convertase 9 26%
9. Hypertension 25%
10. Endothelial Progenitor Cells 23%
11. Endothelial Cells 23%
12. Pulmonary Embolism 23%
13. LDL Cholesterol 21%
14. Acute Coronary Syndrome 21%
15. Hydroxymethylglutaryl-CoA Reductase Inhibitors 20%
16. Transesophageal Echocardiography 20%
17. alirocumab 19%
18. Diabetes Mellitus 19%
19. Lipids 18%
20. Therapeutics 17%
21. Blood Vessels 15%
22. Confidence Intervals 15%
23. Safety 15%
24. Peripheral Arterial Disease 14%
25. Ticagrelor 14%
26. Ischemia 13%
27. Stents 13%
28. Blood Pressure 13%
29. Odds Ratio 13%
30. Neointima 13%
31. Rosiglitazone 12%
32. Atrial Appendage 12%
33. Extremities 12%
34. Coronary Vessels 12%
35. Human Embryonic Stem Cells 12%
36. Stroke 12%
37. Republic of Korea 12%
38. Placebos 11%
39. Angioplasty 11%
40. Elderly 11%
41. Atherosclerosis 11%
42. ST Elevation Myocardial Infarction 11%
43. Hindlimb 11%
44. Smoking 11%